Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Adler

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Swiss Medical Weekly|July 23, 2019
Behçet's syndrome: clinical presentation and prevalence in SwitzerlandRahel A Villiger, Anna-Luisa Stefanski, Véronique Grobéty, et al.
Annals of the Rheumatic Diseases|December 21, 2013
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort studyBurkhard Möller, Menno Pruijm, Sabine Adler, et al.
Swiss Medical Weekly|January 19, 2011
Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case seriesMichael Seitz, Stephan Reichenbach, Harald M Bonel, et al.
Arthritis Care & Research|June 7, 2013
Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot studySabine Adler, Meike Körner, Frauke Förger, et al.
Rheumatology (Oxford, England)|March 28, 2019
Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritisSabine Adler, Stephan Reichenbach, Andrea Gloor, et al.
Journal of Medical Case Reports|May 26, 2019
Peripheral and central nervous system involvement in a patient with primary Sjögren's syndrome: a case reportKathi Ging, Marie-Luise Mono, Mathias Sturzenegger, et al.
Rheumatology (Oxford, England)|February 7, 2014
A simple Baker's cyst? Tocilizumab remits paraneoplastic signs and controls growth of IL-6-producing angiomatoid malignant fibrous histiocytomaPeter M Villiger, Silvia Cottier, Maciej Jonczy, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 2, 2024
Correction to: Low-dose radiotherapy for greater trochanteric pain syndrome-a single-centre analysisMichal Staruch, Silvia Gomez, Susanne Rogers, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 14, 2023
Low-dose radiotherapy for greater trochanteric pain syndrome-a single-centre analysisMichal Staruch, Silvia Gomez, Susanne Rogers, et al.
Rheumatology (Oxford, England)|July 3, 2018
Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritisAndrea D Gloor, Daniel Yerly, Sabine Adler, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Swiss Medical Weekly|July 23, 2019
Behçet's syndrome: clinical presentation and prevalence in SwitzerlandRahel A Villiger, Anna-Luisa Stefanski, Véronique Grobéty, et al.
Annals of the Rheumatic Diseases|December 21, 2013
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort studyBurkhard Möller, Menno Pruijm, Sabine Adler, et al.
Swiss Medical Weekly|January 19, 2011
Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case seriesMichael Seitz, Stephan Reichenbach, Harald M Bonel, et al.
Arthritis Care & Research|June 7, 2013
Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot studySabine Adler, Meike Körner, Frauke Förger, et al.
Rheumatology (Oxford, England)|March 28, 2019
Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritisSabine Adler, Stephan Reichenbach, Andrea Gloor, et al.
Journal of Medical Case Reports|May 26, 2019
Peripheral and central nervous system involvement in a patient with primary Sjögren's syndrome: a case reportKathi Ging, Marie-Luise Mono, Mathias Sturzenegger, et al.
Rheumatology (Oxford, England)|February 7, 2014
A simple Baker's cyst? Tocilizumab remits paraneoplastic signs and controls growth of IL-6-producing angiomatoid malignant fibrous histiocytomaPeter M Villiger, Silvia Cottier, Maciej Jonczy, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 2, 2024
Correction to: Low-dose radiotherapy for greater trochanteric pain syndrome-a single-centre analysisMichal Staruch, Silvia Gomez, Susanne Rogers, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 14, 2023
Low-dose radiotherapy for greater trochanteric pain syndrome-a single-centre analysisMichal Staruch, Silvia Gomez, Susanne Rogers, et al.
Rheumatology (Oxford, England)|July 3, 2018
Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritisAndrea D Gloor, Daniel Yerly, Sabine Adler, et al.
Pageof 5